In this study, genetic testing for mutations in the LMNA gene in a large cohort of patients with FPLD did not result in any of the already known pathogenic mutations, but it revealed three likely pathogenic mutations, along with various changes in other exons and especially introns, whose pathogenicity and subsequent role in the patients’ phenotype remain unclear. The gene discussed is LMNA; the disease is familial partial lipodystrophy.